Past Lecture Archive
Our next STEM Scholars Lecture
will be held September 27, 2016
Cellular Smartphones: How Adult Stem Cells Heal Damaged Tissue
Wednesday, April 20, 2016
Dr. Johnathon Anderson, Exosome Team Leader at the Institute of Regenerative Cures, UC Davis Medical Center will address his current research focused on the roll mesenchymal stem cells play in treating damaged tissue.
Currently there are a few hundred clinical trials taking place with mesenchymal stem cells (MSCs) to treat a variety of different diseases, including cardiovascular diseases. Why is there so much excitement surrounding these living medicines and how do they work? Interestingly, scientists have recently discovered a new, exciting, and more sophisticated type of communication system that stem cells use to talk to one another. Learn about how MSCs use cell-to-cell communication systems to heal damaged tissue.
Advancing Stem Cell & Tissue Engineering Applications for Bladder Disease
Tuesday, March 15, 2016
Dr. Eric Kurzrock, professor of urology and chief of pediatric surgery at UC Davis Children’s Hospital will address his current research focused on stem cell-based approaches for treating bladder disease.
Children born with urologic disorders and adults with bladder cancer often require bladder augmentation or replacement. The current surgery utilizes intestinal segments, which have absorptive and secretory properties that lead to infection and stone formation. Ideally the bladder wall should be replaced with bioengineered tissue from the patient’s own cells. The lack of engineered vessels to facilitate vascularization has prevented further application of stem cell therapy. The Bladder Team at the UC Davis Institute for Regenerative Cures is applying advances in stem cell biology to create bladder tissue that is vascularized for use in patients.
Stormwater as a Resource: Sustainable Projects at Sacramento State
Thursday, February 18, 2016
Professor John Johnston, Department of Civil Engineering, and Professional Engineer Maureen Kerner, Office of Water Programs at Sacramento State, will detail two recently completed campus projects involving stormwater management funded through the California State Water Resources Control Board Proposition 84 Stormwater Grant Program.
Sustainable stormwater management practices are essential to safeguarding our precious water resources and the habitats they provide. According to the U.S. Environmental Protection Agency, stormwater discharges from the urban environment are one of the leading, remaining causes of water quality degradation. This presentation will show how stormwater can be a problem but with proper management, can be used as a sustainable resource.
The Journey of Stem Cells: Material-based systems for engineering new vascular networks
Tuesday, November 24, 2015
Dr. Eduardo A. Silva, Assistant Professor of Biomedical Engineering at the University of California, Davis will address his current research focused on stem cell-based approaches for treating critical limb ischemia (CLI).
For patients who fail to respond to first-line therapies for peripheral artery disease (PAD), the manifestations include critical limb ischemia (CLI). Despite positive results with animal and small-scale clinical studies, large clinical trials of stem cell-based approaches for CLI, have not demonstrated a significant effect. Why has there been such poor correlation between animal studies and clinical trials to date? Discussion will cover some of the challenges involving both engineering and biological aspects.
Stem Cell-Derived Cardiomyocytes to the Rescue!
Wednesday, October 14, 2015
Dr. Deborah Kuo Ti Lieu, Assistant Adjunct Professor of Cardiovascular Medicine at the UC Davis Institute for Regenerative Cures will address her current research focused on treating heart disease using stem cell technology.
Heart disease is the leading cause of morbidity and mortality in the United States. The successful derivation of cardiomyocytes from human pluripotent stem cells presents a new strategy termed “regenerative medicine” in treating heart disease patients. But are these derived cells ready for the task? What are the other possible applications for the human pluripotent stem cell-derived cardiomyocytes?
The Reflect Home: Using solar energy to power the new American home
Thursday, September 24, 2015
Professor Mikael Anderson and Assistant Professor Gareth Figgess from the Construction Management Department at Sacramento State, will detail Sac State’s team effort constructing the solar powered “Reflect Home” on campus. This lecture is presented in collaboration with the Sacramento State One World Initiative: Global Perspectives on Power.
Sacramento State is one of just 20 universities worldwide selected by DOE to compete in the Solar Decathlon which challenges collegiate teams to design, build and operate solar-powered houses that are cost-effective, energy-efficient and attractive. The Solar Decathlon is an intense educational and workforce-development project for Sac State students studying construction management, interior design, mechanical engineering, public relations and business administration. Their goal is to build a net-zero house that’s affordable.
Leukemia Stem Cells: Targeting Acute Myeloid Leukemia's Achilles Heel
Tuesday, April 21, 2015
Dr. Brian Jonas, Assistant Professor at the UC Davis School of Medicine, will address the efforts being taken to combat AML and other bone marrow cancers.
Acute myeloid leukemia (AML) is a heterogeneous group of aggressive clonal bone marrow cancers characterized by the expansion of functionally impaired immature myeloid cells. In 2015, an estimated 20,830 new cases of AML will be diagnosed in the United States with an estimated 12,730 deaths. AML, and other bone marrow cancers, such as acute lymphoblastic leukemia and myelodysplastic syndrome (MDS), are propagated and maintained by chemoresistant and quiescent leukemia stem cells (LSC). Targeted elimination of LSC represents an attractive therapeutic approach to improve outcomes and cure patients with these lethal diseases.
Stem Cell and Gene Therapy Product Manufacturing at the UC Davis GMP Facility - A 5 Year Update
Tuesday, March 17, 2015
Gerhard Bauer, Associate Professor of Hematology/Oncology and Director of the UC Davis Good Manufacturing Practice Facility, will address current stem cell and gene therapy research happening at the UC Davis facility with a 5-year update.
The UC Davis GMP facility, a truly unique and currently the largest academic Good Manufacturing Practice facility in Northern California, has been producing, under strict regulatory oversight, novel clinical-grade stem cell and gene therapy products that have been on the forefront in stem cell research. Highlights, among many other products manufactured, are gene-corrected skin cells derived from patients' own induced pluripotent stem cells for the treatment of the devastating skin-blistering disease epidermolysis bullosa, and an autologous stem cell treatment for blindness.
Farming with Fish: Aquaponics and Urban Agriculture in Sacramento
Thursday, February 19, 2015
Dr. Dudley Burton, Professor in the department of Environmental Studies and Dr. Brook Murphy, Lecturer in the Environmental Studies and Biological Sciences department at Sacramento State, will address their current aquaponics research happening at the Sustainable Technology Optimization Research Center (STORC) at Sacramento State.
As our population grows, a strong movement toward localized food production in non-traditional agricultural areas has begun to take hold. Professors Dudley Burton and Brook Murphy created the aquaponics program to highlight the significance of urban agriculture in addressing global food supply and environmental sustainability issues. Aquaponics farming is a system of aquaculture in which the waste produced by fish or other aquatic animals supplies nutrients for plants grown hydroponically. It uses 90 percent less water than traditional farming methods.